Trial intelligence / Profile preview

QL Block vs TAP Block for Post-prostatectomy Analgesia

NCT03606889Terminated

Sponsor
Jagiellonian University
Start
Jul 2018
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Jagiellonian University. Primary endpoint: Total oxycodone used in the first 24 hours after surgery. Started Jul 2018; status: terminated.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03606889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03606889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call